# The Predictive Value of On-treatment Virological Response for Sustained Virological Response in Chronic Hepatitis C

> **NCT01464008** · — · COMPLETED · sponsor: **Beijing Ditan Hospital** · enrollment: 297 (actual)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** Pegylated interferon alfa-2a and ribavirin

## Key facts

- **NCT ID:** NCT01464008
- **Lead sponsor:** Beijing Ditan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2011-05
- **Final completion:** 2011-09
- **Target enrollment:** 297 (ACTUAL)
- **Last updated:** 2016-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01464008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01464008, "The Predictive Value of On-treatment Virological Response for Sustained Virological Response in Chronic Hepatitis C". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT01464008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*